WorldCare Clinical's WorldPRO Suite Evolves to Support Complex Endpoint Assessment Committee Reviews
WorldCare Clinical
announced a major release of its WorldPRO image management platform, a comprehensive system that collects, integrates and presents data to multiple reviewers in a regulatory compliant, efficient and effective manner. With the new version of WorldPRO, multiple clinicians can now access and evaluate data in preparation of an endpoint assessment committee review.
"We’re seeing an increase in the use of EACs, particularly in oncology trials, partially in response to regulatory agencies looking for an integrated assessment of patient outcomes," said Richard Walovitch, PhD, president of WorldCare Clinical, LLC. "The enhancements we’ve made to our WorldPRO platform ensures that sponsors can benefit from a holistic assessment of disease. Leveraging our relationship with Massachusetts General Hospital, we are able to provide oncology, pathology, dermatology, and oncology reviews by clinicians who apply practices used in patient care to the clinical trial setting."
By providing fully automated functionality for imaging data management, cli nical data management, image analysis, project management, and full trial transparency in a 21 CRF-compliant solution, the WorldPRO platform streamlines and improves the blinded independent central review (BICR) process by ensuring sponsors have complete control over trial data every step of the way.
The latest version includes updated features designed to further enhance the flexibility and configurability of WorldPRO to accommodate complex workflows, integrating the review of radiology, pathology, photography, and clinical data. This integration enables a more efficient review, reducing study timelines and improving data accuracy. In addition to delivering significant operational efficiencies to sponsors, WorldPRO provides complete transparency throughout the course of a trial by enabling sponsors to confirm that all data has been properly obtained and received from investigators before final blinded assessment, and minimizes unnecessary re-reads that can negatively impact chances for FDA approval. WCC’s fully digital process removes bias in data handling, and an efficient data management system streamlines all data capture and transmission to optimize workflow and ensure total control throughout.
Putting Collective Insights Into Action to Advance Cancer Care: Key Examples From ASCO 2025
June 27th 2025At ASCO 2025, clinical operations leaders gained critical insights into how AI tools, bispecific antibodies, and evolving treatment paradigms are reshaping trial design, endpoint selection, and patient stratification.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Funding Cuts Threaten Diversity in Clinical Research
June 27th 2025In this video interview, Kyle McAllister, co-founder, CEO, Trially, discusses how recent federal funding cuts are likely to undermine research focused on underrepresented populations, and why long-term investment in community-based studies is essential to closing persistent health equity gaps.
